OAB-011: Predictors of Unsustained Negativity in Minimal Residual Disease (Mrd)-Negative Transplant-Eligible Newly Diagnosed Multiple Myeloma (MM) Patients Enrolled in the FORTE Trial
Clinical Lymphoma Myeloma & Leukemia（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined